| Carbon nanotubes for delivery of small molecule drugs BS Wong, SL Yoong, A Jagusiak, T Panczyk, HK Ho, WH Ang, G Pastorin Advanced drug delivery reviews 65 (15), 1964-2015, 2013 | 694 | 2013 |
| Classical and non‐classical ruthenium‐based anticancer drugs: towards targeted chemotherapy W Han Ang, PJ Dyson European Journal of Inorganic Chemistry 2006 (20), 4003-4018, 2006 | 641 | 2006 |
| Organometallic ruthenium-based antitumor compounds with novel modes of action WH Ang, A Casini, G Sava, PJ Dyson Journal of Organometallic Chemistry 696 (5), 989-998, 2011 | 452 | 2011 |
| Rational design of platinum (IV) compounds to overcome glutathione-S-transferase mediated drug resistance WH Ang, I Khalaila, CS Allardyce, L Juillerat-Jeanneret, PJ Dyson Journal of the American Chemical Society 127 (5), 1382-1383, 2005 | 396 | 2005 |
| Ruthenium porphyrin compounds for photodynamic therapy of cancer F Schmitt, P Govindaswamy, G Süss-Fink, WH Ang, PJ Dyson, ... Journal of medicinal chemistry 51 (6), 1811-1816, 2008 | 342 | 2008 |
| Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity Z Adhireksan, GE Davey, P Campomanes, M Groessl, CM Clavel, H Yu, ... Nature communications 5 (1), 3462, 2014 | 334 | 2014 |
| Development of organometallic ruthenium− arene anticancer drugs that resist hydrolysis WH Ang, E Daldini, C Scolaro, R Scopelliti, L Juillerat-Jeannerat, ... Inorganic chemistry 45 (22), 9006-9013, 2006 | 298 | 2006 |
| In vitro evaluation of rhodium and osmium RAPTA analogues: The case for organometallic anticancer drugs not based on ruthenium A Dorcier, WH Ang, S Bolano, L Gonsalvi, L Juillerat-Jeannerat, ... Organometallics 25 (17), 4090-4096, 2006 | 247 | 2006 |
| Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms CA Vock, WH Ang, C Scolaro, AD Phillips, L Lagopoulos, ... Journal of medicinal chemistry 50 (9), 2166-2175, 2007 | 235 | 2007 |
| Rational design of an organometallic glutathione transferase inhibitor WH Ang, LJ Parker, A De Luca, L Juillerat‐Jeanneret, CJ Morton, ... Angewandte Chemie International Edition 48 (21), 3854-3857, 2009 | 210 | 2009 |
| Development of nitrile-functionalized ionic liquids for C− C coupling reactions: implication of carbene and nanoparticle catalysts Z Fei, D Zhao, D Pieraccini, WH Ang, TJ Geldbach, R Scopelliti, ... Organometallics 26 (7), 1588-1598, 2007 | 205 | 2007 |
| Induction of immunogenic cell death by chemotherapeutic platinum complexes DYQ Wong Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno …, 2018 | 185 | 2018 |
| Palladium nanoparticles Stabilized by an ionic polymer and ionic liquid: a versatile system for C− C cross-coupling reactions X Yang, Z Fei, D Zhao, WH Ang, Y Li, PJ Dyson Inorganic chemistry 47 (8), 3292-3297, 2008 | 182 | 2008 |
| Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: synthesis, structure, electrochemistry, and cytotoxicity M Auzias, B Therrien, G Süss-Fink, P Štěpnička, WH Ang, PJ Dyson Inorganic chemistry 47 (2), 578-583, 2008 | 176 | 2008 |
| Strategy to tether organometallic ruthenium− arene anticancer compounds to recombinant human serum albumin WH Ang, E Daldini, L Juillerat-Jeanneret, PJ Dyson Inorganic chemistry 46 (22), 9048-9050, 2007 | 172 | 2007 |
| Discovery and investigation of anticancer ruthenium–arene Schiff-base complexes via water-promoted combinatorial three-component assembly MJ Chow, C Licona, D Yuan Qiang Wong, G Pastorin, C Gaiddon, ... Journal of Medicinal Chemistry 57 (14), 6043-6059, 2014 | 169 | 2014 |
| Organometallic Ruthenium Inhibitors of Glutathione‐S‐Transferase P1‐1 as Anticancer Drugs WH Ang, A De Luca, C Chapuis‐Bernasconi, L Juillerat‐Jeanneret, ... ChemMedChem: Chemistry Enabling Drug Discovery 2 (12), 1799-1806, 2007 | 161 | 2007 |
| A supercooled imidazolium iodide ionic liquid as a low-viscosity electrolyte for dye-sensitized solar cells Z Fei, D Kuang, D Zhao, C Klein, WH Ang, SM Zakeeruddin, M Grätzel, ... Inorganic chemistry 45 (26), 10407-10409, 2006 | 156 | 2006 |
| Synthesis and characterization of platinum (IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake WH Ang, S Pilet, R Scopelliti, F Bussy, L Juillerat-Jeanneret, PJ Dyson Journal of medicinal Chemistry 48 (25), 8060-8069, 2005 | 151 | 2005 |
| Revisiting ether-derivatized imidazolium-based ionic liquids Z Fei, WH Ang, D Zhao, R Scopelliti, EE Zvereva, SA Katsyuba, PJ Dyson The Journal of Physical Chemistry B 111 (34), 10095-10108, 2007 | 140 | 2007 |
Mario Lo BelloProfessor of Biochemistry and Clinical BiochemistryVerified email at uniroma2.it
